menu
The glycosylation analysis services market is projected to reach nearly USD 2.5 billion by 2030
Profiling and in-depth characterization of glycosylated molecules in biotherapeutic and research samples require specialized equipment

Therapidly growing pipeline of recombinant glycoprotein therapeutics, especiallythe glycoengineered variants of COVID-19 drugs, has presented lucrativeopportunities for contract service providers with expertise in glycoconjugate /glycan analysis

 

London

 

Roots Analysis has announced the addition of Glycosylation Analysis ServicesMarket, 2021 – 2030 report to itslist of offerings.

 

Profiling and in-depth characterization ofglycosylated molecules in biotherapeutic and research samples requirespecialized equipment and focused expertise, which has prompted the researchinstitutes, clinics and drug developers to outsource glyco-analyticaloperations to contract service providers, that claim to have the requiredskillset and technical infrastructure to assess multiple glycosylationattributes, such as glycan structure, position, linkage, charge andcomposition, in the minimum time.

 

To order this 310+ page report, which features80+ figures and 130+ tables, please visit https://www.rootsanalysis.com/reports/glycosylation-analysis-services-market.html

 

Key Market Insights

 

Presently, over 130industry and non-industry players claim to offer a multitude of glyco-analytical services 

The market ispredominantly characterized by the presence of small firms (having less than50 employees). Around 45% companies offering glycan analysis services arebased in North America. It is worth noting that 90% of these companies offerservices for mapping of glycoprotein macro-heterogeneity, including glycanprofiling and heterogeneity analysis. Further, nearly 80 companies employspectroscopy techniques for glycan pattern and structural analysis.

 

Over 30 organizationsare actively involved in developing over 80 surface glycan targeting drugs

Most of theaforementioned therapies (65%) are in the early stages of development(discovery / preclinical), while more than 30% are being evaluated in theclinical trials. It is worth noting that majority (79%) of the therapies arebeing investigated for the treatment of various oncological disorders withsolid tumors being the most common target.

 

Grants worth over USD180 million been awarded to support research on glycan targeting therapies,since 2016

Till March 2021, over190 grants have been awarded for the research projects related to molecules targetingdisease associated glycans. Around 40% of the total number of grants wereprovided by the National Institute of Allergy and Infectious Diseases (NIAID).

 

Partnership activityin this field has increased at a CAGR of over 30%, between 2015 and 2020    

The highest number ofpartnership agreements (24) were signed in 2020. Majority of the instances(60%) included mergers and acquisitions; this is followed by deals inked forlicensing of drug candidates / technology platforms.

 

NorthAmerica and Europe are expected to capture ~85% ofthe market share by 2030

In terms ofanalytical technique, contracts involving spectroscopy techniques areanticipated to contribute to more than 45% of the total service revenuesgenerated in 2030. Currently, closeto 40% of the total revenues are generated from projectscontracted to well established firms. In the long term, contributions fromsmall firms / start-ups are projected to increase, representing a healthygrowth rate of 24%.

 

 

To request a sample copy / brochure ofthis report, please visit

https://www.rootsanalysis.com/reports/glycosylation-analysis-services-market/request-sample.html

 

KeyQuestions Answered

§ Who are the leadingindustry and non-industry players offering glycan analysis services?

§ Which are the keygeographies where glycan analysis service providers are located?

§ What are the commonanalytical techniques used by the service providers?

§ What are theprevalent R&D trends related to surface glycan targeting therapies?

§ Which surface glycanmolecules are targeted by such therapies?

§ What are the keytherapeutic areas for which such therapies are being / have been developed?

§ Who are the leadingplayers engaged in the development of surface glycan targeting therapies?

§ Which partnershipmodels are commonly adopted by stakeholders in this industry?

§ What are the keyvalue drivers of the merger and acquisition activity within this domain?

§ How is the currentand future opportunity, related to glycan analysis services, likely to bedistributed across key market segments?

 

The USD 2.5+ billion (by 2030) financialopportunity associated with glycosylation analysis services market has been analyzed across the followingsegments:

§  CompanySize

§  SmallCompanies

§  Mid-sizedCompanies

§  LargeCompanies

 

§ Type of AnalyticalTechnique

§  Spectroscopy-based

§  Chromatography-based

§  Microarray-based

§  Electrophoresis-based

 

§ Key GeographicalRegions

§ North America

§ Europe

§ Asia- Pacific and theRest of the World

 

The report alsofeatures inputs from eminent industry stakeholders, according to whom, growingpipeline of glycoprotein therapies and stringent regulatory standards forglyco-analytical characterization, are driving the growth of the glycosylationanalysis services market. The report includes detailed transcripts ofdiscussions (in reverse chronological order) held with the followingexperts:

 

Thereport includes detailed profiles of key players (listed below), eachfeaturing an overview of the company, its financial information (if available), a descriptionof the glycosylation analysis service(s) offered, details of recentdevelopments along with an informed future outlook.

§ CD BioGlyco

§ Creative Biolabs

§ Creative Proteomics

§ Thermo FisherScientific

§ Glykos Finland

§ glyXera

§ Ludger

§ Mithra Biotechnology

§ Protagen ProteinServices

§ Protein Works

§ Savyon Diagnostics

§ Syngene

 

For additionaldetails, please visit 

https://www.rootsanalysis.com/reports/glycosylation-analysis-services-market.htmlor email sales@rootsanalysis.com

 

You may also beinterested in the following titles:

1.    Biologics Fill / FinishServices Market (2ndEdition): Industry Trends and Global Forecasts, 2020-2030

2.    Vaccine ContractManufacturing Market (3rd Edition): Industry Trends and GlobalForecasts, 2021-2030

3.    Top Selling BiologicsMarket, 2021-2030

4.    BiopharmaceuticalCROs Market, Industry Trends and Global Forecasts, 2021-2030

5.    Cell Line Developmentand Characterization Services Market (2ndEdition), 2020- 2030

6.    BiopharmaceuticalContract Manufacturing Market (4th Edition): IndustryTrends and Global Forecast to 2030

 

About Roots Analysis

Roots Analysis is one of the fastest growingmarket research companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com

 

Contact Information

RootsAnalysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis